Using motivational techniques to reduce cardiometabolic risk factors in long term psychiatric inpatients: A naturalistic interventional study by Ringen, Petter Andreas et al.
1 
 
Using Motivational Techniques to Reduce Cardiometabolic Risk Factors in Long Term 
Psychiatric Inpatients:  A Naturalistic Interventional Study 
Petter Andreas Ringen*:  
Division of Mental Health and Addiction, Oslo University Hospital and NORMENT, KG 
Jebsen Centre, University of Oslo, Ullevål Hospital. P.O.Box 4956 Nydalen, 0424 Oslo, 
Norway.  
Email: p.a.ringen@medisin.uio.no.  
 
Ragnhild S. Falk:  
Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, P.O.Box 4950 
Nydalen, 0424 Oslo Norway.  
Email: rs@ous-hf.no.  
 
Bjørnar Antonsen:  
Department of Psychiatry, Lovisenberg Diaconal Hospital, P.O.Box 4970 Nydalen 
0440 Oslo, Norway.  
Email: bjornar.antonsen1000@gmail.com.  
 
Ann Faerden:  
Division of Mental Health and Addiction, Oslo University Hospital, and NORMENT, KG 
Jebsen Centre, University of Oslo, Ullevål Hospital, P.O.Box 4956 Nydalen, 0424 Oslo, 
Norway.  
Email:  ann.farden@medisin.uio.no.  
 
Asgeir Mamen:  
Kristiania University College, P.O.Box 1190 Sentrum, 0107 Oslo, Norway.  
Email: Asgeir.Mamen@kristiania.no.  
 
Eline B. Rognli:  
Division of Mental Health and Addiction, Oslo University Hospital, Ullevål Hospital. 
P.O.Box 4956 Nydalen, 0424 Oslo, Norway. 
Email: elboka@ous-hf.no.  
 
Dag K. Solberg: 
.
  
Skjelfoss Psychiatric Center, Lukas Foundation and Center for Psychopharmacology 
Diakonhjemmet Hospital. Center for Psychopharmacology, Diakonhjemmet Hospital. 
Postboks 23 Vinderen, 0319 Oslo, Norway.  
Email: dag.solberg@diakonsyk.no.  
 
 
Egil W. Martinsen: 
Division of Mental Health and Addiction, Oslo University Hospital and University of Oslo, 
Ullevål Hospital. P.O.Box 4956 Nydalen, 0424 Oslo, Norway.  
Email:  e.w.martinsen@medisin.uio.no.  
 
Ole A. Andreassen:  
NORMENT, KG Jebsen Centre, Oslo University Hospital, and University of Oslo, Ullevål 
Hospital, Building 49, P.O. Box 4956 Nydalen, 0424 Oslo, Norway.  
Formatted: English (U.S.)
2 
 
Email: o.a.andreassen@medisin.uio.no.  
*Corresponding Author 
 
  
3 
 
Abstract 
Background: People with severe mental illness have markedly reduced life expectancy; 
cardiometabolic disease is a major cause. Psychiatric hospital inpatients have elevated levels of 
cardiometabolic risk factors and are to a high degree dependent of the routines and facilities of the 
institutions. Studies of lifestyle interventions to reduce cardiometabolic risk in psychiatric inpatients 
are few. The current study aimed at assessing the feasibility and effects of a lifestyle intervention 
including Motivational Interviewing (MI) on physical activity levels, cardiometabolic risk status and 
mental health status in psychotic disorder inpatients.  
Methods: Prospective naturalistic intervention study of 83 patients at long term inpatient psychosis 
treatment wards in South-Eastern Norway. Patients were assessed 3-6 months prior to, at start and 6 
months after a life-style intervention program including training of staff in MI, simple changes in 
routines and improvements of facilities for physical exercise. Assessments were done by clinical staff 
and included level of physical activity, motivation, life satisfaction, symptom levels (MADRS, AES-C, 
PANSS, and GAF) as well as anthropometric and biochemical markers of cardiometabolic risk. A 
mixed model was applied to analyze change over time. 
Results:  A total of 88 % of patients received MI interventions, with a mean of 2.5 MI interventions 
per week per patient. The physical activity level was not increased, but activity level was positively 
associated with motivation and negatively associated with positive symptoms. Triglyceride levels and 
amount of smoking were significantly reduced and a significant decrease in symptom levels was 
observed.  
Conclusions: The current results suggest that a simple, low cost life-style intervention program 
focusing on motivational change is feasible and may reduce symptoms and improve cardiometabolic 
risk in psychosis patients in long term treatment facilities.  Similar programs may easily be 
implemented in other psychiatric hospitals. 
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Background 
People with severe mental disorders carry a significantly higher risk for premature deaths due to 
cardiovascular disease (1). Some of this increased risk seems to be linked to the genetic susceptibility 
of the disease itself (2), but several unhealthy lifestyle habits are also possible causes (1). Tobacco 
smoking is highly prevalent (3), and has well-known detrimental effects on health and mortality, also 
in schizophrenia (4, 5). Many people with severe mental illness have unhealthy diets, often driven by 
poor economy or loss of interest in personal maintenance (6).  Side effects of especially the second 
generation antipsychotics are regarded as an important contributor to the increased risk for the 
metabolic syndrome in schizophrenia (7, 8).  
A balanced diet may reduce cardiovascular disease (CVD) risk factors (9-11). Physical exercise has 
beneficial effects on CVD risk factors such as body mass index (BMI), and blood  lipids (12) and may 
reduce mortality (13). Improvement of physical fitness seems likely to reduce the elevated mortality 
in this patient group (14). Exercise programs are feasible and may also improve mental well-being 
and overall outcome among patients with schizophrenia (15). Increased physical exercise or 
improvements in dietary habits are thus possible strategies for reducing the increased mortality in 
schizophrenia.  
There are, however, many barriers to life-style changes in the general population, and in addition 
several obstacles for changes specifically among patients with severe mental illness (16). Some of 
these, such as negative symptoms and reduced initiative, are part of the mental disorder itself. Many 
patients are ambivalent to making a change in their lifestyle habits and need help in their 
motivational process (17). An increased focus on facilitating life-style changes related to 
cardiometabolic risk in the mental health care system would be of great importance.  
Different motivational methods have been used for facilitating behavioural change in psychiatric 
settings (18-20), with positive results for increased physical exercise in schizophrenia patients in 
outpatient and day care settings (21-24). Motivational interviewing (MI) was originally developed for 
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facilitating behavioural change in substance use disorders (25), but has spread to other areas of 
medicine where behavior change  is crucial (26, 27). Despite the accumulated evidence, 
comprehensive interventions aiming to improve physical fitness among patients with mental illness 
have only to a small degree been implemented in psychiatric clinics, and research on feasibility and 
effects of training programs in a hospital setting is scarce. To our knowledge no previous study has 
addressed the usefulness of MI for increasing physical activity or other lifestyle changes in severe 
mental illness in an inpatient setting. There is a need for low cost interventions in this area which are 
feasible to implement in daily clinical routines.  
A project for improvement of lifestyle factors associated with cardiometabolic risk was carried out at 
several long term inpatient psychosis treatment wards in Southeastern Norway. Comprehensive 
clinical data at baseline confirmed high levels of cardiometabolic risk factors including obesity, 
smoking and unhealthy eating habits (28). The current project aimed to answer the following 
research questions: How feasible is it to implement a simple lifestyle improvement program based on 
MI interventions targeting cardiometabolic health, investigating if level of motivation is associated 
with interventions or lifestyle changes? Further,  is the intervention associated with increased levels of 
physical activity, reduced cardiometabolic risk factors or improve the mental health status?  
Methods 
Setting 
The current study was carried out at The Oslo University Hospital (OUH) and the private inpatient 
psychiatric care facility Skjelfoss Psychiatric Centre - Lukas Foundation (SPC). At the OUH the two 
participating departments were in three different buildings at Gaustad in Oslo Municipality and at 
two sites at Dikemark in Asker Municipality, west of Oslo.  The SPC is located in Hobøl Municipality 
south of Oslo.  All departments provide inpatient treatment for long term psychiatric patients serving 
catchment areas in the South-East Health Region of Norway. The departments have the capacity to 
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administer compulsory measures and included high security wards. The total number of beds was 
116.  
Inclusion criteria 
Inpatients, aged between 18 – 65 years and with  DSM-IV diagnoses of schizophrenia, schizoaffective 
disorder, schizophreniform disorder, psychotic disorder NOS, bipolar I  or bipolar disorder NOS. 
Exclusion criteria were established cognitive deficit (IQ < 70), brain damage, BMI<17.5, inability to 
speak Scandinavian or English language.  All participants had to be able and willing to give informed 
consent to participate in the study.  
Design 
A project for lifestyle change was conceived of by the local administration and clinicians involving 
changing clinical routines at all wards relying on existing resources, e.g. local personnel performing all 
tasks. Interventions should be clinically relevant and thus be transformed into permanent changes of 
practice. Practical obstacles for establishing an adequate control condition and ethical considerations 
ruled out a randomized, controlled study. The current study is thus a prospective observational study 
of patient related conditions before and after the introduction of a lifestyle enhancement program 
targeting cardiometabolic health, following as many patients as possible through their course of 
inpatient treatment. 
The intervention was preceded by Start assessments 0-4 weeks prior, and followed by End 
assessments performed 6-7 months after starting date for the interventions. The End assessments 
were compared to the assessments of the pre-intervention period (Figure 1), which also included 
Baseline assessments 3-6 months prior that served as control condition.  
Figure 1. Design: Assessment periods at each ward 
 
Consecutive patients were included during a 12- month period which differed in onset between 
wards.  Inclusion to the study at the first ward started in January 2013 and ended at the last ward in 
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March 2015. Effort was made to have a continuous inclusion unbiased of patient related factors. The 
intervention was carried out at all wards and implemented at a date specified for each of the wards.   
Intervention 
The intervention aimed at a life style change to reduce cardiometabolic risk. A user representative 
and the clinical staff at all participating wards were involved in the planning of the intervention, 
which consisted of three components:  
1) Motivational interventions 
Training in motivational interviewing (MI) was mandatory for all staff and was organized by certified 
instructors as a two-day intensive course with follow-up practical guidance. The course included 
lectures, discussion, role play and group guidance with the MI-expert. The first day of the course was 
held within a week before the defined starting day for interventions, the second within four weeks 
after. Patients were informed about the purpose and implications of the interventions. Motivational 
interventions for enhancing physical activity, dietary improvement and smoking cessation were 
applied in different settings: 1) Daily motivating interaction with patients was encouraged. All 
patients were offered at least 15 minutes structured MI per week, often performed during hikes in 
the countryside. In order to help adherence to protocol, staff used a daily recording form where type 
of MI-interventions, patients’ response to the MI-interventions and patients’ physical activity was 
recorded. This form is attached (in English translation) as supplementary material. During all physical 
training activities, the staff focused on individual feedback and encouragement. 2) Adherence to 
treatment plans (see next component) would lead to instant positive verbal feedback and attention 
from staff (reinforcement), while adherence failure would receive neutral feedback (no 
reinforcement). 3) Staff would behave in a facilitating manner e.g. by changing to training clothes at 
times for assistance in physical activity. 4) Logbooks were given to every participant for personal 
logging of activities and results. 5) T-shirts with a logo and slogan were issued for promoting a sense 
of togetherness. 
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2) Physical activity as part of individual treatment plans 
Patients were offered a comprehensive physical training program and participants and staff together 
made weekly individual treatment plans including a goal of 30 minutes physical exercise three times 
per week as a minimum. The physical exercise consisted of any continuous physical activity, e.g. 
walking, running, ball-play, cycling, weight lifting or gymnastics.   
3) Establishment of a basic infrastructure for physical activity and improved diet 
An infrastructure for physical activity enhancement was implemented by establishing a gym (weight 
lifting equipment and treadmill and/or stationary bicycles), a high intensity interval training group as 
well as low intensity walking/cycling groups at each site. The gym was manned by a physiotherapist 
at regular hours giving individual exercise advice. The program for interval training “the Hill Run” was 
developed. Physiotherapists made regular visits to all wards in order to secure the quality of the 
program and ensure implementation. Details about “The Hill Run» is provided as supplementary 
material. The infrastructure was made available at the intervention starting date. The intervention 
also included improvement in diet. During the project between-meals offerings of vegetables and 
fruit were introduced and sugar containing beverages were replaced with water or beverages with 
artificial sweeteners. 
Assessments at Baseline only 
Data was gathered from interviews and medical charts. Time of admission, smoking, and use of 
current psychopharmacological medication were recorded. Height was measured. The participants 
were diagnosed with the Structural Clinical Interview for DSM-IV for axis I disorders (SCID-I) (29). 
More details about data collection is reported elsewhere (28). 
Assessments at Baseline, Start and End 
Cardiometabolic risk factors were assessed according to established guidelines (De Hert et al 2008). 
Weight was measured and Body Mass Index (BMI) was calculated. Waist circumference was 
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measured with a horizontal tape measurement from the top of the right iliac crests. S-Glucose, 
HbA1c and fasting plasma lipids (Total Cholesterol, High Density Lipoprotein - LDL, Low Density 
Lipoprotein - LDL and Triglycerides –TG) were measured.  Smoking habits were reported. 
Level of physical activity was assessed as the product of the rating scores of the questions of 
frequency of sessions (never: 0, less than once a week: 0.5, weekly: 1, 2-3 times a week: 2.5, almost 
daily: 5), intensity of sessions (low effort: 1, moderate effort: 2, almost maximum effort: 3) and 
duration of sessions (less than 15 minutes: .10, 15-29 minutes: .38, 30-60 minutes: .75, more than 60 
minutes: 1.0) of physical activity in the HUNT questionnaire (30-32).  Sedentary behavior was 
assessed by daily waking hours of inactivity.  
We used the life satisfaction item from the HUNT study, categorizing life satisfaction on a 7-point 
scale from extremely discontent to extremely content. Self-esteem was assessed by the Rosenberg 
Self-Esteem Scale (33). The level of psychotic symptoms was measured with The Positive and 
Negative Symptom Scale (PANSS)(34), depressive symptoms with the Montgomery Asberg 
Depression Rating Scale (MADRS)(35). Global symptoms and psychosocial functioning were 
measured by the Global Assessment of Functioning Scale (GAF), the scores were split into scales of 
symptoms (GAF-S) and functioning (GAF-F) to improve psychometric properties (36). Apathy was 
measured with the abridged clinical version of the Apathy Evaluation Scale (AES-C-Apathy)(37, 38).  
Motivation was measured by applying two visual analog scales from 0 (minimum) to 10 (maximum) 
assessing perceived importance for change and readiness for change.  
Weekly assessments during the intervention period 
Recordings were made of number of MI session per patient per week. 
Diagnostics and symptom assessments were done by medical doctors and psychologists who were 
part of the regular staff and had participated in a training course in SCID and PANSS assessments and 
regularly diagnostic consensus meetings led by clinically well experienced specialists.  
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Statistics:  
All analyses were done using the IBM Statistical Package for the Social Sciences (SPSS) version 25.0 
(SPSS Inc, Chicago, IL, USA). Descriptive statistics were presented as frequencies, proportions, mean 
and median with range. Group comparisons were evaluated with independent sample t-tests and Chi 
square tests as appropriate. Bivariate analyses were performed with Pearson’s r and Spearman’s rho 
for normally distributed or skewed data, correspondingly. 
Linear mixed model analyses were performed to estimate the fixed effects of time (Baseline, Start 
and End) on the different outcome (dependent) variables. Individual patients and time were set as 
random factors. No covariance structure was pre-specified (i.e. unstructured). After model fit, we 
estimated marginal means for time to explore differences between the time points. If significant 
changes by time were observed, a posteriori analyses were performed to explore the potential 
contribution of key variables with clinical interest. Thus, sex, BMI or use of antipsychotics was 
included as fixed effects, one at a time, in these analyses. Further, to explore the potential 
contribution of motivation, depressivity and positive and negative symptom status for changes in 
physical activity, the following variables were included, one at a time, as fixed effects: motivation 
(importance and readiness), PANSS-positive symptoms, MADRS and AES-C Apathy.  A secondary 
analysis was performed, substituting physical activity by sedentary behavior, in order to study 
physical inactivity.   
 
Results 
Of a total of 114 patients who met the inclusion criteria, 83 patients (73 %) signed informed consent. 
Mean age was 40.1 years (n=80), 57 of 82 (69.5 %) were male, 57 (76.0 %) had schizophrenia, 7 
(10.7 %) had schizoaffective disorder and 10 (13.4 %) had bipolar disorder or other psychotic disorder. 
Median admission time prior to the intervention was 24 months (range 1- 240), n=31. At Start 43 of 
50 patients (86.0 %) used antipsychotic medication. Some patients had attenuated or absent positive 
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psychotic symptoms at the time of inclusion. Due to variable staff resources, time constraints and 
sometimes non-compliance with assessment protocol, full datasets at all time points could not be 
obtained. There were no significant differences in assessments at Start between patients with or 
without assessments at Baseline. Levels of physical activity and motivation at both Start and End 
were obtained for 16 patients. Data on smoking at both Start and End were obtained for 40 patients. 
Weekly MI reports were obtained for 79 patients (95 %) at week 1 (Start), but declined to 50 % at 
week 13. A total of n=73 (88 %) of the participants received MI-sessions during the intervention 
period. Mean MI sessions per patient per week during the 6 months follow-up was 2.5 (SD 2.3). 
Uncorrected post hoc analyses showed that mean number of MI sessions per patient per week was 
1.4 (SD 1.3) at OUS wards and 5.3 (SD 2.0) at SPC wards (p<.001). 
The levels of physical activity increased from Start to End in 38 % (6/16). Motivation levels at End 
were higher in the group with increase in physical activity; importance: 8.0 (SD 2.1) vs 4.9 (3.8), 
p=.056; readiness: 6.7 (1.4) vs 4.2 (4.1), p=.048. Among the smokers at Start, 17% (2/12) had quitted 
smoking at End, while among 28 initial non-smokers none started smoking (p<.001).  
The mixed linear model analyses showed no statistically significant changes in estimated marginal 
means (EMMs) for physical activity or inactivity over time. There was a nominal trend for a reduction 
in sedentary behavior over time, although not statistically significant (p=.473). The reduction from 
Start to End of depressive symptoms (MADRS) was statistically significant (p=.009). There was a 
significant decrease of PANSS positive symptoms from Baseline to End (p=.006). The increase in self-
esteem was borderline significant from Start to End (p=.051).  There was a non-significant nominal 
decrease in both measures for motivation from Start to End (p=?), while for the AES-C and the PANSS 
negative there were no apparent changes (Table 1).  
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Table 1. Linear mixed model analyses of clinical assessments at the Baseline, Start and End time 
points; estimation of marginal means (EMM) of time with standard errors (S.E.) 
   
BASELINE  
 
START 
 
END 
Variables N* n EMM S.E. n EMM S.E. n EMM S.E. 
Physical Activity Index 58 21 3.6 .6 51 3.0 .3 18 3.1 .5 
Daily hours of inactivity 56 23 8.6 .7 47 8.0 .5 17 7.4 .7 
Motivation, importance 72 55 7.0 .4 49 7.0 .4 19 6.4 .6 
Motivation, readiness 72 54 5.9 .4 48 6.3 .4 19 5.5 .6 
Self-esteem (Rosenberg)  60 21 25.7 .6 52 27.0 1.0 19 28.8 1.4 
Life satisfaction 58 48 3.8 .2 18 3.5 .3 26 3.7 .2 
GAF S 50 20 39.0 1.8 49 37.0 1.8 25 36.7 2.2 
GAF F 50 20 37.8 1.6 49 36.1 1.6 25 38.1 2.2 
PANSS positive 60 18 22.3 1.3 57 19.6 1.1 23 18.2 1.3 
PANSS negative 60 17 20.1 1.7 56 21.3 1.6 23 19.9 1.2 
PANSS general 60 17 43.3 2.3 56 39.6 1.5 23 38.2 1.8 
MADRS 71 16 13.5 1.1 57 12.8 .9 23 10.3 1.1 
AES-C Apathy 53 19 39.7 2.0 42 36.7 1.2 18 37.7 1.7 
BMI, kg/m
2
 59 54 29.3 .9 34 30.0 1.0 17 29.4 0.9 
Waist, cm 39 24 110.5 2.6 26 109.7 3.1 13 109.5 3.1 
Glucose, mmol/L 57 21 5.6 .1 46 5.5 .1 17 5.5 .1 
HbA1C, % 58 22 5.6 .2 48 5.4 .1 16 5.6 .1 
Insulin, pmol/L 32 0 - - 24 99.6 11.7 12 123.6 20.2 
Cholesterol, mmol/L 57 22 5.1 .2 47 5.4 .1 17 5.2 .2 
Trigycerides, mmol/L 57 22 1.8 .3 47 2.2 .2 17 1.5 .2 
HDL-cholesterol, mmol/L 58 22 1.1 .1 48 1.4 .2 17 1.4 .1 
LDL-cholesterol, mmol/L 57 20 3.0 .2 47 3.4 .1 16 3.3 .2 
CRP, mg/L 25 21 3.5 .9 11 3.8 1.2 11 3.8 1.2 
Vit DTOT, nmol/L 21 10 46.7 6.5 17 60.2 5.6 16 58.8 4.9 
*: N of measures included in the linear mixed model. Bold numbers: Comparison with End yields significance at the .05 level. GAF: Global 
Assessment of Functioning. PANSS: Positive And Negative Syndrome Scale. MADRS: Montgomery Asberg Depression Rating Scale. AES-C 
Apathy: Apathy Evaluation Scale. BMI: Body Mass Index.  HbA1C: Glycosylated Hemoglobin. HDL: High Density Lipoprotein Cholesterol. LDL: 
Low Density Lipoprotein. EMM: Estimated Marginal Means. S.E: Standard Error. 
 
There was a significant decrease in blood triglyceride levels after intervention (p=.002).  For other 
blood lipids levels and CRP there were no clear trends for the intervention period (Start to End). 
There was a significant increase in D-vitamin levels from Baseline to End (p=.010) (Table 1). Adjusting 
for sex, BMI or use of antipsychotics at Start in the linear mixed model did not affect main findings.  
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Adjusted linear mixed model analyses showed a highly significant positive effect of motivation at 
Baseline (importance, p<.001, readiness, p=.011) and a significant negative effect of positive 
symptoms at Baseline on changes in levels of physical activity (p=.016). The MADRS and the AES-C at 
Baseline showed no significant effects on physical activity (Table 2). Similar analyses of sedentary 
behavior at baseline or institution (OUS or SPC) showed no significant effects of any of these 
potential covariates (data not shown).   
Table 2. Adjusted linear mixed model analysis of physical activity (PA Index) at the Baseline, Start and 
End time points; estimation of fixed effects.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BL: Baseline. PANSS: Positive And Negative Syndrome Scale. MADRS: Montgomery Asberg Depression Rating Scale. AES-C Apathy: Apathy 
Evaluation Scale. CI: confidence intervals. 
 
Discussion 
The current study assessed  a naturalistic intervention for lifestyle improvement including 
motivational interviewing to reduce cardiometabolic risk in a naturalistic long term inpatient ward 
setting. The study was observational, and relied on the institutions’ own staff for all interventions 
and assessments.  The implementation of this low cost intervention was fairly successful, with an 
adequate number of MI-sessions, particularly in the first phase of the interventions.  We found a 
significant reduction in triglyceride level and smoking after intervention. We did not detect any 
Variable 
 
Coefficient 95 % CI p 
Time BL 0.49 -0.00 to 0.97 .050 
 
Start -0.38 -1.53 to 0.76 .498 
 
End (ref) 
  Motivation, importance 
 
0.23 0.14 to 0.32 <.001
Time BL 0.37 -0.23 to 0.96 .199 
 Start -0.45 -1.78 to 0.89 .496 
 End (ref)   
Motivation, readiness  0.17 0.04 to 0.30 .011 
Time BL 0.50 .09 to 0.91 .022 
 
Start 0.24 -1.04 to 1.52 .701 
 
End (ref) 
  PANSS positive -0.06 -0.11 to -0.01 .016
Time BL 0.53 -0.21 to 1.27 .136 
 Start 0.28 -1.06 to 1.61 .664 
 End (ref)   
MADRS  0.03 -0.04 to 0.09 .394 
Time BL 0.78 -0.25 to 1.80 .111 
 
Start -0.19 -1.45 to 1.07 .755 
 
End (ref) 
  AES-C Apathy 
 
-0.06 -0.14 to 0.03 .170
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significant increase in mean activity level, but observed a significant decrease in depressive symptom 
level. We found change in physical activity to be positively associated with motivation and negatively 
associated with positive symptoms. To the best of our knowledge, the current findings are unique 
and highly clinically relevant as studies of low cost lifestyle interventions are scarce among 
psychiatric inpatient populations.   
The findings of incomplete implementation of parts of the program may be taken as an indication 
that feasibility depended on available clinical resources and manpower. However, an evaluation of 
the health care system was beyond the scope of the present study. Thus, we have no systematic 
measures of budgets, work load, available staff resources at the long-term wards during the project 
period. However, we note that the long-term hospital SPC, with rural location, low patient turnover 
and no acute ward, seems to have more MI sessions than the larger hospital OUS located in the city, 
with a high number of acute ward admissions per year. The design of the study with implementation 
in regular clinical service by the local staff, led to missing data. We have no indications that missing 
collection of data affected the quality of the assessments, or resulted in systematic bias in the data. 
The failure to improve the mean activity level and the lack of association between MI sessions and 
change in physical activity may suggest that the intervention was too weak or non-targeted. Previous 
studies suggest that quite comprehensive regimens are needed to make changes in physical activity 
level, and often provide modest effects (39-41). However, sedentary behavior is increasingly 
considered as a more important target for interventions (42) and is possibly easier to improve. In fact, 
we observed a declining pattern in the inactivity level which did not reach statistical significance. 
Thus, the current findings indicate that there is a potential of low-cost cardiometabolic interventions 
in chronic inpatient settings. However, to support the notion that the current lack of significant effect 
is a type II error, more studies are needed.  
We found that higher level of motivation was associated with improvement in physical activity level, 
but mean levels of neither of these improved during the intervention.  A possible interpretation of 
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these results is that interventions for physical activity enhancement only succeeded in targeting a 
subgroup of motivated patients.  A proportion of patients seemed to reduce motivation during the 
project period, although not significant. This seems to reason with non-systematic evaluation of the 
registered individual patients’ reports suggesting that some psychological “saturation” effects might 
have been at play. Unfortunately, due to low N it was not possible to explore changes in symptoms 
or motivation across groups with or without improvement in physical activity.  
We found that triglyceride level was significantly reduced from Start to End independently of BMI or 
use of antipsychotics, and there was no increase in other lipid levels.  However, this result must be 
interpreted with caution since there were no decrease in triglyceride level from Baseline to End.  
Interestingly, the change in triglyceride level doesn’t seem to be associated with change in activity 
level. We could speculate that the change is related to improved diet, which is previously shown to 
improve lipid levels in schizophrenia patients (43). Changing diet in a hospital setting depends on 
motivation both in patients and staff, which was a clear goal of the present intervention. Further, 
two patients quitted smoking during the interventions, and none started. It is conceivable that this 
highly clinically meaningful life style change is attributable to the staff’s motivational efforts which 
included smoking cessation. Smoking cessation may reduce the metabolism of antipsychotics and 
thus increase the effect of medication. This can potentially affect both activity level and symptom 
load. However due to the low number we were not able to control for this possible association. 
Level of depression was significantly decreased from Start to End, which suggests that it was 
independent of the general symptom improvement during hospitalization. Decreasing depression 
level after interventions for enhancement of physical activity has been shown in previous meta-
analyses (39, 44).  As we did not detect any increase in mean activity level, it is possible that the 
observed reduction in the MADRS score could be associated directly with the motivational work (45) 
and a potential change in ward atmosphere (46). A previous analysis of the Baseline data found high 
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level of depression to be associated with low level of physical activity (28). However, the level of 
depression was not associated with change in physical activity in the current intervention study. 
The finding of decrease in positive symptoms was only significant from Baseline to End and could 
hence not be associated with the intervention specifically. However, reduced level of positive 
symptoms was associated with an increase in physical activity. A reduction in positive symptoms 
during exercise interventions has been shown in other studies (39, 47). This might have clinical 
importance.  
The main strength of the study is the naturalistic design with comprehensive clinical descriptions and 
the assessments of changes in “real-life” psychosis-treatment hospital wards. We argue that this 
design has important advantages for representativity and translational value, and our methods and 
experiences could be useful for other lifestyle enhancement projects. However, as the design was 
not experimental with e.g. a control group, there are limitations in interpreting effects of the 
interventions. There were incomplete data in the time series due to instability in data gathering 
resources of the clinical staff in the project period. This gave a risk for type II errors and limited the 
testing of hypotheses in subgroups. Bias could be introduced if there were any systematic selection 
of patients for assessments or missing data. However, we have tested for differences associated with 
missing data, and found no clear bias. We have no indications that other selection mechanisms were 
at play, but bias cannot be ruled out. Site or ward specific differences could also affect the results, 
but we had not statistical power for evaluating site-dependent factors.  The mixed model analyses 
made it possible to test hypotheses of datasets with incomplete time series with a high retention of 
statistical power. The study of change in a naturalistic design made it impossible to compare change 
in a control group in the same time period. We were thus not able to control for effects related to 
time, something that is a concern in a setting of active treatment. By comparing the change in the 
intervention period to the pre-intervention period, we were nevertheless able to make some 
assessments of the contributions of time as a factor. Further, it can be argued that dramatic changes 
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over some months in the intervention period are not expected in this population of predominantly 
chronically ill patients where over 50 % had  more than 2 years duration of admission at the time of 
inclusion. We did not have records of the staff’s attitudes and behavior or ward atmosphere, hence, 
potential changes in these factors associated with the interventions could not be controlled for. 
Another limitation is that we have no objective measurements of level of physical activity. 
Conclusions 
In conclusion, the current study shows that a combined intervention for lifestyle change, with 
emphasis on motivational work, may have positive effects on psychiatric symptom level as well as on 
cardiometabolic risk in psychiatric inpatients settings. The study highlights both the importance of 
motivational factors in lifestyle change and the need for evidence based practices to guide milieu 
therapeutic interventions at inpatient hospital wards.  The interventional program described in the 
current study relied on existing staff resources for the actual patient interventions and could easily 
be implemented elsewhere, provided  motivated staff with necessary resources.  
Viewing a psychiatric hospital as a place of retention is still a reality in minds, routines and 
legislations, and staffing of wards will often be more focused on avoiding unacceptable risks than on 
the improvement of clinical practice. A psychiatric hospital environment, however, has opportunities 
for the involvement of both users and staff in the planning and provision of better services with 
potential positive impact on highly important aspects of health. 
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